\documentclass[10pt,a4paper]{article} % Packages \usepackage{fancyhdr} % For header and footer \usepackage{multicol} % Allows multicols in tables \usepackage{tabularx} % Intelligent column widths \usepackage{tabulary} % Used in header and footer \usepackage{hhline} % Border under tables \usepackage{graphicx} % For images \usepackage{xcolor} % For hex colours %\usepackage[utf8x]{inputenc} % For unicode character support \usepackage[T1]{fontenc} % Without this we get weird character replacements \usepackage{colortbl} % For coloured tables \usepackage{setspace} % For line height \usepackage{lastpage} % Needed for total page number \usepackage{seqsplit} % Splits long words. %\usepackage{opensans} % Can't make this work so far. Shame. Would be lovely. \usepackage[normalem]{ulem} % For underlining links % Most of the following are not required for the majority % of cheat sheets but are needed for some symbol support. \usepackage{amsmath} % Symbols \usepackage{MnSymbol} % Symbols \usepackage{wasysym} % Symbols %\usepackage[english,german,french,spanish,italian]{babel} % Languages % Document Info \author{Hardi (Hardi01)} \pdfinfo{ /Title (disease-categorized-drugs.pdf) /Creator (Cheatography) /Author (Hardi (Hardi01)) /Subject (Disease Categorized Drugs Cheat Sheet) } % Lengths and widths \addtolength{\textwidth}{6cm} \addtolength{\textheight}{-1cm} \addtolength{\hoffset}{-3cm} \addtolength{\voffset}{-2cm} \setlength{\tabcolsep}{0.2cm} % Space between columns \setlength{\headsep}{-12pt} % Reduce space between header and content \setlength{\headheight}{85pt} % If less, LaTeX automatically increases it \renewcommand{\footrulewidth}{0pt} % Remove footer line \renewcommand{\headrulewidth}{0pt} % Remove header line \renewcommand{\seqinsert}{\ifmmode\allowbreak\else\-\fi} % Hyphens in seqsplit % This two commands together give roughly % the right line height in the tables \renewcommand{\arraystretch}{1.3} \onehalfspacing % Commands \newcommand{\SetRowColor}[1]{\noalign{\gdef\RowColorName{#1}}\rowcolor{\RowColorName}} % Shortcut for row colour \newcommand{\mymulticolumn}[3]{\multicolumn{#1}{>{\columncolor{\RowColorName}}#2}{#3}} % For coloured multi-cols \newcolumntype{x}[1]{>{\raggedright}p{#1}} % New column types for ragged-right paragraph columns \newcommand{\tn}{\tabularnewline} % Required as custom column type in use % Font and Colours \definecolor{HeadBackground}{HTML}{333333} \definecolor{FootBackground}{HTML}{666666} \definecolor{TextColor}{HTML}{333333} \definecolor{DarkBackground}{HTML}{E39494} \definecolor{LightBackground}{HTML}{FBF1F1} \renewcommand{\familydefault}{\sfdefault} \color{TextColor} % Header and Footer \pagestyle{fancy} \fancyhead{} % Set header to blank \fancyfoot{} % Set footer to blank \fancyhead[L]{ \noindent \begin{multicols}{3} \begin{tabulary}{5.8cm}{C} \SetRowColor{DarkBackground} \vspace{-7pt} {\parbox{\dimexpr\textwidth-2\fboxsep\relax}{\noindent \hspace*{-6pt}\includegraphics[width=5.8cm]{/web/www.cheatography.com/public/images/cheatography_logo.pdf}} } \end{tabulary} \columnbreak \begin{tabulary}{11cm}{L} \vspace{-2pt}\large{\bf{\textcolor{DarkBackground}{\textrm{Disease Categorized Drugs Cheat Sheet}}}} \\ \normalsize{by \textcolor{DarkBackground}{Hardi (Hardi01)} via \textcolor{DarkBackground}{\uline{cheatography.com/212750/cs/46606/}}} \end{tabulary} \end{multicols}} \fancyfoot[L]{ \footnotesize \noindent \begin{multicols}{3} \begin{tabulary}{5.8cm}{LL} \SetRowColor{FootBackground} \mymulticolumn{2}{p{5.377cm}}{\bf\textcolor{white}{Cheatographer}} \\ \vspace{-2pt}Hardi (Hardi01) \\ \uline{cheatography.com/hardi01} \\ \end{tabulary} \vfill \columnbreak \begin{tabulary}{5.8cm}{L} \SetRowColor{FootBackground} \mymulticolumn{1}{p{5.377cm}}{\bf\textcolor{white}{Cheat Sheet}} \\ \vspace{-2pt}Not Yet Published.\\ Updated 17th June, 2025.\\ Page {\thepage} of \pageref{LastPage}. \end{tabulary} \vfill \columnbreak \begin{tabulary}{5.8cm}{L} \SetRowColor{FootBackground} \mymulticolumn{1}{p{5.377cm}}{\bf\textcolor{white}{Sponsor}} \\ \SetRowColor{white} \vspace{-5pt} %\includegraphics[width=48px,height=48px]{dave.jpeg} Measure your website readability!\\ www.readability-score.com \end{tabulary} \end{multicols}} \begin{document} \raggedright \raggedcolumns % Set font size to small. Switch to any value % from this page to resize cheat sheet text: % www.emerson.emory.edu/services/latex/latex_169.html \footnotesize % Small font. \begin{multicols*}{3} \begin{tabularx}{5.377cm}{x{2.4885 cm} x{2.4885 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Hypertension}} \tn % Row 0 \SetRowColor{LightBackground} \seqsplit{Angiotensin-Converting} Enzyme (ACE) Inhibitors & Benazepril, Captopril, Cilazapril, Enalapril, Fosinopril, Lisinopril, Perindopril, Quinapril, Ramipril, Trandolapril \tn % Row Count 6 (+ 6) % Row 1 \SetRowColor{white} Alpha1-Adrenergic Antagonists & Doxazosin, Prazosin, Terazosin \tn % Row Count 8 (+ 2) % Row 2 \SetRowColor{LightBackground} Angiotensin Receptor Blockers (ARBs) & Azilsartan, Candesartan, Eprosartan, Irbesartan, Iosartan, Olmesartan, Telmisartan, Valsartan \tn % Row Count 13 (+ 5) % Row 3 \SetRowColor{white} Beta1-Adrenergic Antagonists, nonselective & Nadolol, Propranolol, Timolol \tn % Row Count 16 (+ 3) % Row 4 \SetRowColor{LightBackground} Beta1-Adrenergic Antagonists, beta1-selective & Atenolol, Bisoprolol, Metoprolol, Nebivolol \tn % Row Count 19 (+ 3) % Row 5 \SetRowColor{white} Beta1-Adrenergic Antagonists, nonselective with intrinsic sympathomimetic activity (ISA) & Pindolol \tn % Row Count 24 (+ 5) % Row 6 \SetRowColor{LightBackground} Beta1-Adrenergic Antagonists, beta1-selective with ISA & Acebutolol \tn % Row Count 27 (+ 3) % Row 7 \SetRowColor{white} Beta1-Adrenergic Antagonists with alpha1-blocking activity & Labetalol \tn % Row Count 30 (+ 3) \end{tabularx} \par\addvspace{1.3em} \vfill \columnbreak \begin{tabularx}{5.377cm}{x{2.4885 cm} x{2.4885 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Hypertension (cont)}} \tn % Row 8 \SetRowColor{LightBackground} Calcium Channel Blockers, dihydropyridine & Amlodipine, Felodipine, Nifedipine \tn % Row Count 3 (+ 3) % Row 9 \SetRowColor{white} Calcium Channel Blockers, nondihydropyridine & Diltiazem, Verapamil \tn % Row Count 6 (+ 3) % Row 10 \SetRowColor{LightBackground} Centrally Acting Antihypertensive Agents & Clonidine, Methyldopa \tn % Row Count 8 (+ 2) % Row 11 \SetRowColor{white} Direct Renin Inhibitors & Aliskiren \tn % Row Count 10 (+ 2) % Row 12 \SetRowColor{LightBackground} Diuretics, potassium-sparing & Amiloride, Spironolactone \tn % Row Count 12 (+ 2) % Row 13 \SetRowColor{white} Diuretics, thiazide & Hydrochlorothiazide, Chlorthalidone, Indapamide, Metolazone \tn % Row Count 15 (+ 3) % Row 14 \SetRowColor{LightBackground} ACE Inhibitors/Calcium Channel Blockers Combinations & \seqsplit{Perindopril/Amlodipine} \tn % Row Count 18 (+ 3) % Row 15 \SetRowColor{white} ACE \seqsplit{Inhibitors/Diuretics} Combinations & \seqsplit{Cilazapril/Hydrochlorothiazide}, \seqsplit{Enalapril/Hydrochlorothiazide}, \seqsplit{Lisinopril/Hydrochlorothiazide}, \seqsplit{Perindopril/Indapamide}, \seqsplit{Quinapril/Hydrochlorothiazide}, \seqsplit{Ramipril/Hydrochlorothiazide} \tn % Row Count 27 (+ 9) % Row 16 \SetRowColor{LightBackground} ARB/Diuretic Combination & \seqsplit{Azilsartan/Chlorthalidone}, Candesartan/-, Eprosartan/-, Irbesartan/-, Iosartan/-, Olmesartan/-, Telmisartan/-, \seqsplit{Valsartan/Hydrochlorothiazide} \tn % Row Count 34 (+ 7) \end{tabularx} \par\addvspace{1.3em} \vfill \columnbreak \begin{tabularx}{5.377cm}{x{2.4885 cm} x{2.4885 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Hypertension (cont)}} \tn % Row 17 \SetRowColor{LightBackground} Beta1-Adrenergic \seqsplit{Antagonist/Diuretics} Combinations & \seqsplit{Atenolol/Chlorthalidone}, \seqsplit{Pindolol/Hydrochlorothiazide} \tn % Row Count 3 (+ 3) % Row 18 \SetRowColor{white} Calcium Channel Blocker/ARB Combinations & \seqsplit{Amlodipine/Telmisartan} \tn % Row Count 5 (+ 2) % Row 19 \SetRowColor{LightBackground} Calcium Channel Blocker/HMG-CoA Reductase Inhibitor Combinations & \seqsplit{Amlodipine/Atorvastatin} \tn % Row Count 9 (+ 4) % Row 20 \SetRowColor{white} Diuretic Combinations & \seqsplit{Hydrochlorothiazide/Amiloride}, \seqsplit{Hydrochlorothiazide/Triamterene}, \seqsplit{Hydrochlorothiazide/Spironolactone} \tn % Row Count 14 (+ 5) \hhline{>{\arrayrulecolor{DarkBackground}}--} \SetRowColor{LightBackground} \mymulticolumn{2}{x{5.377cm}}{Hypertension (High Blood Pressure): A condition where the force of blood against the artery walls is consistently too high.} \tn \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{5.377cm}{x{2.4885 cm} x{2.4885 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Depression}} \tn % Row 0 \SetRowColor{LightBackground} Antipsychotics, second-generation & Aripiprazole, Brexpiprazole, Olanzapine, Quetiapine (extended), Risperidone \tn % Row Count 4 (+ 4) % Row 1 \SetRowColor{white} Dual Action Antidepressants & Bupropion, Mirtazapine \tn % Row Count 6 (+ 2) % Row 2 \SetRowColor{LightBackground} Irreversible Monoamine Oxidase Inhibitors & Phenelzine, Tranylcypromine \tn % Row Count 9 (+ 3) % Row 3 \SetRowColor{white} NMDA Receptor Antagonists & Esketamine \tn % Row Count 11 (+ 2) % Row 4 \SetRowColor{LightBackground} Reversible Monoamine Oxidase-A Inhibitor & Moclobemide \tn % Row Count 13 (+ 2) % Row 5 \SetRowColor{white} Selective Serotonin Reuptake Inhibitors & Citalopram, Escitalopram, Fluoxetine, Fluvoxamine, Paroxetine (Immediate, Controlled-release), Sertraline \tn % Row Count 19 (+ 6) % Row 6 \SetRowColor{LightBackground} \seqsplit{Serotonin-Norepinephrine} Reuptake Inhibitors & Desvenlafaxine, Duloxetine, Levomilnacipran, Venlafaxine \tn % Row Count 22 (+ 3) % Row 7 \SetRowColor{white} Serotonin Modulators & Trazodone, Vilazodone, Vortioxetine \tn % Row Count 24 (+ 2) % Row 8 \SetRowColor{LightBackground} Tricyclic Antidepressants & Amitriptyline, Clomipramine, Desipramine, Doxepin, Imipramine, Nortriptyline, Trimipramine \tn % Row Count 29 (+ 5) % Row 9 \SetRowColor{white} Natural Health Products & \seqsplit{S-adenosylmethionine} \tn % Row Count 31 (+ 2) \hhline{>{\arrayrulecolor{DarkBackground}}--} \SetRowColor{LightBackground} \mymulticolumn{2}{x{5.377cm}}{Depression: A mood disorder that causes a persistent feeling of sadness and loss of interest and can interfere with your daily activities} \tn \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{5.377cm}{x{2.4885 cm} x{2.4885 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Attention Deficit Hyperactivity Disorder}} \tn % Row 0 \SetRowColor{LightBackground} Amphetamine-based Agents & Dextroamphetamine (Immediate, Sustained - release tablets), Lisdexamfetamine, Mixed Salt Amphetamine (Extended Release) \tn % Row Count 6 (+ 6) % Row 1 \SetRowColor{white} \seqsplit{Methylphenidate-based} Agents & Methylphenidate (Immediate, Sustained, Controlled, Bilayer Controlled - release tablets) \tn % Row Count 11 (+ 5) % Row 2 \SetRowColor{LightBackground} Alpha2-Adrenergic Agonists & Clonidine, Guanfacine \tn % Row Count 13 (+ 2) % Row 3 \SetRowColor{white} Antidepressants, dual action & Bupropion \tn % Row Count 15 (+ 2) % Row 4 \SetRowColor{LightBackground} Antidepressants, \seqsplit{serotonin-norepinephrine} reuptake inhibitors (SNRIs) & Venlafaxine \tn % Row Count 19 (+ 4) % Row 5 \SetRowColor{white} Antidepressants, tricyclic & Desipramine, Imipramine, Nortriptyline \tn % Row Count 21 (+ 2) % Row 6 \SetRowColor{LightBackground} Antipsychotics, second-generation & Risperidone \tn % Row Count 23 (+ 2) % Row 7 \SetRowColor{white} Norepinephrine Reuptake Inhibitors & Atomoxetine \tn % Row Count 25 (+ 2) \hhline{>{\arrayrulecolor{DarkBackground}}--} \SetRowColor{LightBackground} \mymulticolumn{2}{x{5.377cm}}{Attention-deficit hyperactivity disorder (ADHD): The most common pediatric neuropsychiatric disorder causing inattention, hyperactivity and impulsivity} \tn \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{5.377cm}{X} \SetRowColor{DarkBackground} \mymulticolumn{1}{x{5.377cm}}{\bf\textcolor{white}{Serotonin \& Norepinephrine Reuptake Inhibitor}} \tn \SetRowColor{LightBackground} \mymulticolumn{1}{p{5.377cm}}{\vspace{1px}\centerline{\includegraphics[width=5.1cm]{/web/www.cheatography.com/public/uploads/hardi01_1750190724_Serotonin - NE Reuptake Inhibitor.png}}} \tn \hhline{>{\arrayrulecolor{DarkBackground}}-} \SetRowColor{LightBackground} \mymulticolumn{1}{x{5.377cm}}{A class of antidepressants that work by blocking the reuptake of the neurotransmitter norepinephrine and dopamine, thus increasing their levels in the brain} \tn \hhline{>{\arrayrulecolor{DarkBackground}}-} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{5.377cm}{x{2.4885 cm} x{2.4885 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Rheumatoid Arthritis}} \tn % Row 0 \SetRowColor{LightBackground} Amino salicylates & Sulfasalazine \tn % Row Count 1 (+ 1) % Row 1 \SetRowColor{white} Antimalarial Agents & Hydroxychloroquine \tn % Row Count 2 (+ 1) % Row 2 \SetRowColor{LightBackground} Immunomodulators & Leflunomide, Methotrexate \tn % Row Count 4 (+ 2) % Row 3 \SetRowColor{white} B-cell Depletors & Rituximab \tn % Row Count 5 (+ 1) % Row 4 \SetRowColor{LightBackground} Interleukin-1 (IL-1) Inhibitors & Anakinra \tn % Row Count 7 (+ 2) % Row 5 \SetRowColor{white} Interleukin-6 (IL-6) Inhibitors & Tocilizumab, Sarilumab \tn % Row Count 9 (+ 2) % Row 6 \SetRowColor{LightBackground} T-cell Costimulation Inhibitors & Abatacept \tn % Row Count 11 (+ 2) % Row 7 \SetRowColor{white} Tumor Necrosis Factor-alpha (TNF-alpha) Inhibitors & Adalimumab, Certolizumab, Etanercept, Golimumab, Infliximab \tn % Row Count 14 (+ 3) % Row 8 \SetRowColor{LightBackground} Janus Kinase Inhibitors & Baricitinib, Tofacitinib citrate, Upadacitinib \tn % Row Count 17 (+ 3) \hhline{>{\arrayrulecolor{DarkBackground}}--} \SetRowColor{LightBackground} \mymulticolumn{2}{x{5.377cm}}{Rheumatoid Arthritis (RA): A chronic autoimmune disease that primarily affects joints, causing pain, swelling and stiffness} \tn \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{5.377cm}{x{2.4885 cm} x{2.4885 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Osteoarthritis}} \tn % Row 0 \SetRowColor{LightBackground} Analgesics & Acetaminophen, Morphine, Oxycodone, Tramadol \tn % Row Count 3 (+ 3) % Row 1 \SetRowColor{white} COX-2 Inhibitors & Celecoxib \tn % Row Count 4 (+ 1) % Row 2 \SetRowColor{LightBackground} NSAIDs, acetic acid derivatives & Diclofenac, Indomethacin, Sulindac \tn % Row Count 6 (+ 2) % Row 3 \SetRowColor{white} NSAIDs, naphthylakanone derivatives & Nubumetone \tn % Row Count 8 (+ 2) % Row 4 \SetRowColor{LightBackground} NSAIDs, oxicams & Piroxicam, Meloxicam \tn % Row Count 9 (+ 1) % Row 5 \SetRowColor{white} NSAIDs, propionic acid derivatives & Flurbiprofen, Ibuprofen, Ketoprofen, Naproxen, Naproxen sodium, Tiaprofenic acid \tn % Row Count 13 (+ 4) % Row 6 \SetRowColor{LightBackground} NSAIDs, salicylic acid derivatives & ASA, Diflunisal \tn % Row Count 15 (+ 2) % Row 7 \SetRowColor{white} \seqsplit{NSAIDs/Gastroprotection} Combination & \seqsplit{Diclofenac/Misoprostol}, \seqsplit{Naproxen/Esomeprazole} \tn % Row Count 18 (+ 3) % Row 8 \SetRowColor{LightBackground} \seqsplit{Serotonin-Norepinephrine} Reuptake Inhibitors & Duloxetine \tn % Row Count 21 (+ 3) % Row 9 \SetRowColor{white} Capsicum Derivatives & Capsaicin \tn % Row Count 22 (+ 1) % Row 10 \SetRowColor{LightBackground} Nonsteroidal Anti-inflammatory Agents & Diclofenac Diethylamine, Diclofenac Sodium \tn % Row Count 25 (+ 3) % Row 11 \SetRowColor{white} Corticosteroids, Intra-articular & Betamethasone \seqsplit{acetate/betamethasone} sodium phosphate, Triamcinolone acetonide, Methylprednisolone acetate \tn % Row Count 31 (+ 6) \end{tabularx} \par\addvspace{1.3em} \vfill \columnbreak \begin{tabularx}{5.377cm}{x{2.4885 cm} x{2.4885 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Osteoarthritis (cont)}} \tn % Row 12 \SetRowColor{LightBackground} \seqsplit{Corticosteroid/Synovial} Fluid Replacement, Intra-articular & Hyaluronic acid/triamcinolone hexacetonide \tn % Row Count 3 (+ 3) % Row 13 \SetRowColor{white} Synovial Fluid Replacement & Sodium hyaluronate \tn % Row Count 5 (+ 2) \hhline{>{\arrayrulecolor{DarkBackground}}--} \SetRowColor{LightBackground} \mymulticolumn{2}{x{5.377cm}}{Osteoarthritis: Most common type of arthritis, characterized by the gradual breakdown of cartilage in joints (Common affected areas: spine, hands, hips or knees)} \tn \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{5.377cm}{x{2.4885 cm} x{2.4885 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{5.377cm}}{\bf\textcolor{white}{Osteoporosis}} \tn % Row 0 \SetRowColor{LightBackground} Anabolic Agents & Romosozumab, Teriparatide \tn % Row Count 2 (+ 2) % Row 1 \SetRowColor{white} Biphosphonates & Alendronate, Risedronate, Zoledronic Acid \tn % Row Count 5 (+ 3) % Row 2 \SetRowColor{LightBackground} Biphosphonates + Nutritional Supplements & Alendronate/Vitamin D \tn % Row Count 7 (+ 2) % Row 3 \SetRowColor{white} Calcitonin Peptides & Calcitonin salmon, subcutaneous \tn % Row Count 9 (+ 2) % Row 4 \SetRowColor{LightBackground} Nutritional Supplements & Calcium, Vitamin D \tn % Row Count 11 (+ 2) % Row 5 \SetRowColor{white} RANK Ligand Inhibitors & Denosumab \tn % Row Count 13 (+ 2) % Row 6 \SetRowColor{LightBackground} Selective Estrogen Receptor Modulators & Raloxifene, Conjugated \seqsplit{estrogen/bazedoxifene} \tn % Row Count 16 (+ 3) \hhline{>{\arrayrulecolor{DarkBackground}}--} \SetRowColor{LightBackground} \mymulticolumn{2}{x{5.377cm}}{Osteoporosis: A skeletal disorder characterized by compromised bone strength predisposing a person to an increased risk of fracture (weakened bone)} \tn \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} % That's all folks \end{multicols*} \end{document}